FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

406443008: Omalizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2004. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2150273010 Omalizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2158095018 Omalizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2150273010 Omalizumab (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2150273010 Omalizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2158095018 Omalizumab en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2158095018 Omalizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
50361000195111 omalizumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
64541000195116 Omalizumab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
191991000077111 omalizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
191991000077111 omalizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
50361000195111 omalizumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
64541000195116 Omalizumab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Omalizumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier (core metadata concept)
Omalizumab Is a Immunosuppressant (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Omalizumab Is a Respiratory system agent (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Omalizumab Is a agent d'anticorps monoclonal false Inferred relationship Existential restriction modifier (core metadata concept)
Omalizumab Has disposition Immunomodulator (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Omalizumab Is a anticorps monoclonal chimérique souris-humain d'isotype IgG false Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing omalizumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Omalizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Omalizumab 150 mg powder for injection 5 mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Omalizumab Inferred relationship Existential restriction modifier (core metadata concept)
Omalizumab only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Omalizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Omalizumab-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Omalizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Omalizumab only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Omalizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely omalizumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Omalizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely omalizumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Omalizumab Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start